Search Results - "Michelson, L"

Albuminuria in chronic heart failure: prevalence and prognostic importance by Jackson, Colette E, MB ChB, Solomon, Scott D, MD, Gerstein, Hertzel C, Prof, Zetterstrand, Sofia, PhD, Olofsson, Bertil, PhD, Michelson, Eric L, Prof, Granger, Christopher B, Prof, Swedberg, Karl, Prof, Pfeffer, Marc A, Prof, Yusuf, Salim, Prof, McMurray, John JV, Prof

“…Summary Background Increased excretion of albumin in urine might be a marker of the various pathophysiological changes that arise in patients with heart…”
Get full text

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients by SOLOMON, Scott D, ANAVEKAR, Nagesh, PFEFFER, Marc A, SKALI, Hicham, MCMURRAY, John J. V, SWEDBERG, Karl, YUSUF, Salim, GRANGER, Christopher B, MICHELSON, Eric L, WANG, Duolao, POCOCK, Stuart

“…Left ventricular function is a principal determinant of cardiovascular risk in patients with heart failure. The growing number of patients with preserved…”
Get full text

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved by Rogers, Jennifer K., Pocock, Stuart J., McMurray, John J.V., Granger, Christopher B., Michelson, Eric L., Östergren, Jan, Pfeffer, Marc A., Solomon, Scott D., Swedberg, Karl, Yusuf, Salim

“…Aims Heart failure is characterized by recurrent hospitalizations, but often only the first event is considered in clinical trial reports. In chronic diseases,…”
Get full text

Sexual quality of life after the treatment of gynecologic cancer: what women want by Hubbs, J. L., Dickson Michelson, E. L., Vogel, R. I., Rivard, C. L., Teoh, D. G. K., Geller, Melissa A.

“…Purpose While the incidence of sexual dysfunction after treatment for gynecologic malignancies is well documented, few studies describe how patients want…”
Get full text

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program by Ariti, Cono A., MSc, Cleland, John G.F., MD, Pocock, Stuart J., PhD, Pfeffer, Marc A., MD, PhD, Swedberg, Karl, MD, PhD, Granger, Christopher B., MD, McMurray, John J.V., MD, Michelson, Eric L., MD, Östergren, Jan, MD, PhD, Yusuf, Salim, MD, DPhil

“…Background Conventional composite outcomes in heart failure (HF) trials, for example, time to cardiovascular death or first HF hospitalization, have recognized…”
Get full text

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank by FELKER, G. Michael, ALLEN, Larry A, GRANGER, Christopher B, POCOCK, Stuart J, SHAW, Linda K, MCMURRAY, John J. V, PFEFFER, Marc A, SWEDBERG, Karl, DUOLAO WANG, YUSUF, Salim, MICHELSON, Eric L

“…The goal of this study was to identify potentially novel laboratory markers of risk in chronic heart failure patients. Although a variety of prognostic markers…”
Get full text

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure by HILLEGE, Hans L, NITSCH, Dorothea, DE ZEEUW, Dick, POCOCK, Stuart, VAN VELDHUISEN, Dirk J, PFEFFER, Marc A, SWEDBERG, Karl, MCMURRAY, John J. V, YUSUF, Salim, GRANGER, Christopher B, MICHELSON, Eric L, ÖSTERGREN, Jan, CORNEL, Jan Hein

“…Decreased renal function has been found to be an independent risk factor for cardiovascular outcomes in patients with chronic heart failure (CHF) with markedly…”
Get full text

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme by MacDonald, Michael R, Petrie, Mark C, Varyani, Fumi, Ostergren, Jan, Michelson, Eric L, Young, James B, Solomon, Scott D, Granger, Christopher B, Swedberg, Karl, Yusuf, Salim, Pfeffer, Marc A, McMurray, John J V

“…To determine whether the risk of adverse cardiovascular (CV) outcomes associated with diabetes differs in patients with low and preserved ejection fraction…”
Get full text

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program by CASTAGNO, Davide, SKALI, Hicham, TAKEUCHI, Madoka, SWEDBERG, Karl, YUSUF, Salim, GRANGER, Christopher B, MICHELSON, Eric L, PFEFFER, Marc A, MCMURRAY, John J. V, SOLOMON, Scott D

“…The aim of this study was to explore the relationship between baseline resting heart rate and outcomes in patients with chronic heart failure (HF) according to…”
Get full text

Predictors of mortality and morbidity in patients with chronic heart failure by Pocock, Stuart J., Wang, Duolao, Pfeffer, Marc A., Yusuf, Salim, McMurray, John J.V., Swedberg, Karl B., Östergren, Jan, Michelson, Eric L., Pieper, Karen S., Granger, Christopher B.

“…Aims We aimed to develop prognostic models for patients with chronic heart failure (CHF). Methods and results We evaluated data from 7599 patients in the CHARM…”
Get full text

Uterine Cervical Sarcoma With a Novel RET-SPECC1L Fusion in an Adult: A Case Which Expands the Homology Between RET-rearranged and NTRK-rearranged Tumors by Weisman, Paul S., Altinok, Morgan, Carballo, Erica V., Kushner, David M., Kram, Jessica J.F., Ladanyi, Marc, Chiang, Sarah, Buehler, Darya, Dickson Michelson, Elizabeth L.

Get full text

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure by SOLOMON, Scott D, DOBSON, Joanna, PFEFFER, Marc A, POCOCK, Stuart, SKALI, Hicham, MCMURRAY, John J. V, GRANGER, Christopher B, YUSUF, Salim, SWEDBERG, Karl, YOUNG, James B, MICHELSON, Eric L

“…Patients with chronic heart failure (HF) are at increased risk of both fatal and nonfatal major adverse cardiovascular events. We used data from the…”
Get full text

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program by Allen, Larry A., Felker, G. Michael, Pocock, Stuart, McMurray, John J.V., Pfeffer, Marc A., Swedberg, Karl, Wang, Duolao, Yusuf, Salim, Michelson, Eric L., Granger, Christopher B.

“…Aims The prevalence and importance of liver function test (LFT) abnormalities in a large contemporary cohort of heart failure patients have not been…”
Get full text

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure by Castagno, Davide, MD, Skali, Hicham, MD, MSc, Takeuchi, Madoka, MS, Swedberg, Karl, MD, PhD, Yusuf, Salim, MBBS, DPhil, Granger, Christopher B., MD, Michelson, Eric L., MD, Pfeffer, Marc A., MD, PhD, McMurray, John J.V., MD, Solomon, Scott D., MD

“…Objectives The aim of this study was to explore the relationship between baseline resting heart rate and outcomes in patients with chronic heart failure (HF)…”
Get full text

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial by McMurray, John JV, Östergren, Jan, Swedberg, Karl, Granger, Christopher B, Held, Peter, Michelson, Eric L, Olofsson, Bertil, Yusuf, Salim, Pfeffer, Marc A

“…Angiotensin II type 1 receptor blockers have favourable effects on haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when…”
Get full text

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial by Granger, Christopher B, McMurray, John JV, Yusuf, Salim, Held, Peter, Michelson, Eric L, Olofsson, Bertil, Östergren, Jan, Pfeffer, Marc A, Swedberg, Karl

“…Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients with chronic heart failure (CHF). A substantial proportion of patients, however,…”
Get full text

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program by OLSSON, Lars G, SWEDBERG, Karl, DUCHARME, Anique, GRANGER, Christopher B, MICHELSON, Eric L, MCMURRAY, John J. V, PUU, Margareta, YUSUF, Salim, PFEFFER, Marc A

“…We assessed the risk of adverse cardiovascular (CV) outcomes associated with atrial fibrillation (AF) in the Candesartan in Heart failure-Assessment of…”
Get full text

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial by Granger, Bradi B, Swedberg, Karl, Ekman, Inger, Granger, Christopher B, Olofsson, Bertil, McMurray, John JV, Yusuf, Salim, Michelson, Eric L, Pfeffer, Marc A

“…Chronic heart failure (CHF) is an important cause of hospital admission and death. Poor adherence to medication is common in some chronic illnesses and might…”
Get full text

Body mass index and prognosis in patients with chronic heart failure : Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program by KENCHAIAH, Satish, POCOCK, Stuart J, GRANGER, Christopher B, MCMURRAY, John J. V, SOLOMON, Scott D, DUOLAO WANG, FINN, Peter V, ZOMOFF, Leonardo A. M, SKALI, Hicham, PFEFFER, Marc A, YUSUF, Salim, SWEDBERG, Karl, MICHELSON, Eric L

“…In individuals without known cardiovascular disease, elevated body mass index (BMI) (weight/height2) is associated with an increased risk of death. However, in…”
Get full text

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program by O'MEARA, Eileen, CLAYTON, Tim, YUSUF, Salim, SWEDBERG, Karl, PFEFFER, Marc A, MCENTEGART, Margaret B, MCMURRAY, John J. V, PINA, Ileana L, GRANGER, Christopher B, OSTERGREN, Jan, MICHELSON, Eric L, SOLOMON, Scott D, POCOCK, Stuart

“…We wished to test previous hypotheses that sex-related differences in mortality and morbidity may be due to differences in the cause of heart failure or in…”
Get full text